These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16101581)

  • 1. Virtual screening for anti-HIV-1 RT and anti-HIV-1 PR inhibitors from the Thai medicinal plants database: a combined docking with neural networks approach.
    Sangma C; Chuakheaw D; Jongkon N; Saenbandit K; Nunrium P; Uthayopas P; Hannongbua S
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):417-29. PubMed ID: 16101581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
    Gupta P; Kumar R; Garg P; Singh IP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents.
    Cele FN; Ramesh M; Soliman ME
    Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
    Vadivelan S; Deeksha TN; Arun S; Machiraju PK; Gundla R; Sinha BN; Jagarlapudi SA
    Eur J Med Chem; 2011 Mar; 46(3):851-9. PubMed ID: 21272964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
    Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
    SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones.
    Prabhakar YS; Rawal RK; Gupta MK; Solomon VR; Katti SB
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):431-7. PubMed ID: 16101582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action.
    Vilar S; Santana L; Uriarte E
    J Med Chem; 2006 Feb; 49(3):1118-24. PubMed ID: 16451076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial chemistry as a tool for targeting different stages of the replicative HIV-1 cycle.
    Mugnaini C; Petricci E; Corelli F; Botta M
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):387-401. PubMed ID: 16101579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of nevirapine derivatives insensitive to the K103N and Y181C HIV-1 reverse transcriptase mutants.
    Saparpakorn P; Hannongbua S; Rognan D
    SAR QSAR Environ Res; 2006 Apr; 17(2):183-94. PubMed ID: 16644557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors.
    Rawal RK; Kumar A; Siddiqi MI; Katti SB
    J Mol Model; 2007 Jan; 13(1):155-61. PubMed ID: 16969668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
    Li Z; Han J; Chen HF
    Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1.
    Frecer V; Burello E; Miertus S
    Bioorg Med Chem; 2005 Sep; 13(18):5492-501. PubMed ID: 16054372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial synthesis of anti-HIV agents--a review.
    Sriram D; Yogeeswari P; Nagappa AN
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):377-85. PubMed ID: 16101578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative molecular surface analysis (CoMSA) for virtual combinatorial library screening of styrylquinoline HIV-1 blocking agents.
    Niedbala H; Polanski J; Gieleciak R; Musiol R; Tabak D; Podeszwa B; Bak A; Palka A; Mouscadet JF; Gasteiger J; Le Bret M
    Comb Chem High Throughput Screen; 2006 Dec; 9(10):753-70. PubMed ID: 17168681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
    Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
    Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum.
    el-Mekkawy S; Meselhy MR; Nakamura N; Tezuka Y; Hattori M; Kakiuchi N; Shimotohno K; Kawahata T; Otake T
    Phytochemistry; 1998 Nov; 49(6):1651-7. PubMed ID: 9862140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
    Douali L; Villemin D; Cherqaoui D
    J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase.
    Zhou Z; Madrid M; Madura JD
    Proteins; 2002 Dec; 49(4):529-42. PubMed ID: 12402361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.